CHARITY COMMISSION
Lung Cancer Nursing
UK
ANNUAL REPORT AND ACCOUNTS FINANCIAL YEAR ENDING
JANUARY 2025
Charitable Incorporated Organisation number: 1160011
LUNG CANCER NURSING UK I FIFTEEN Rosehill. Montgomery Way, Rosehill Estate CARLISLE, CAI 2RW

TRUSTE￿. REPORT
Forthew4reDded 31January2025
About LCNUK
Lung Cancer Nursing UK was established in 1998 to support the advancement of health by providing nurses
who specialise in the treatment of patients with lung cancer or mesothelioma with support, education and
the opportunityto communicate and network with peers; and to provide a national voice on clinical and
strategic issues for specialist lung cancer nurses. The organisation became a charitable incorporated
organisation ICIOI in 2015.
Membership is open to any specialist nurse who spends more than 50% of their working week or clinical
activities in caring for patients with lung cancer and or mesothelioma within the NHS environment. A
separate associate membership scheme is available for Lung Cancer Navigators/Care Coordinators and
a550ciate membership is also open to those who do not meet the criteria for full membership. The
experience and clinical background of the members working environments are very diverse, including,
palliative care. oncology (cancer centres or units) respirdtory medicine. community and others. this affords
the organisation a wealth of knowledge into which member5 can access.
The activities of the CIO fall into four distinct categories, these are as follow5:
Clinical
Improving the care lung cancer patients receive.
Disseminating best practice and sharing information and knowledge
Developmental
Keeping members up-to-date with the latest lung cancer news through our e-bulletins
Hi8hli8hting new developments in the UK.
Encouraging regional participation within LCNUK
Education
Providing a forum to disseminate new developments. skills, treatments and practice through
educational programmes, annual conference, resources and publications
Sharing clinical updates and best practi￿ with members
Supporting and fostering audit and research in lung cancer and within the role of the LCNS
Professional
Providing sUPPOrt and netrNorkin8, infrastructure and opportunities.
CampaiBning for and supporting the role of the lung cancer nurse specialist
Providing a voice on clinica5 and strategic issues.
Highlighting the specialist role of nurses in caring for people with lung cancer and mesothelioma
Representing lun8 cancer nurse specialists on national and international bodies and organisations
LUNG CANCER NURSING UK
IA ¢harltsble Incorptsvdtsd organtsatlon iao-tharlty Number 116(¥MII
Page I

TBUSIEES, REPORT
FOrth@￿￿end￿ 3lJ4nuary2025
2025 Business Priorities
The Trustees present their annual report together with the financial statements of the charity for the year I
February 2024 to 31 January 2025. The Trustees confirm thatthe Annual Report and Financial Statements of
the charity comply with the current statutory requirements, the requirements of the charitys governing
document and the provisions of the Statement of Recommended Practice ISORPI applicable to charities
preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and
Republic of Ireland IFRS1021 (effective l January 20191.
The Trustees have complied with the duty in part I section 4 of the Charities Att 2011 to have due regard to
public benefit guidance published by the Charity Commission. A detailed report of the activities undertaken
and achievements by the Charity to further its charitable purposes for the publlc benefit is given below
In 2025, LCNUK priorities were unchanged:
Professional
To act as advocates for patients with lung cancer on national professional bodies such as NICEIBTOG.
To represent the lung cancer nurse specialist on professional bodies and committees and provide a voice on
strategic i55ues at a regional and national level.
To promote the lung cancer nurse specialist role and its benefits on an intemational platform.
To share best practice in lung cancer and mesothelioma care.
Developmental
To continue production and circulation of a monthly e-bulletin to share best prartice and highlight lung
cancer and relevant nursing news and events.
To maintain the LCNUK website creatin& sharing and signposting to relevant news and events.
Education and Clinical
Annual Conference June 2024-To provide ongoing professional education to lung cancer nurse specialists
through its annual conference.
To provide regular educational programmes of activity including webinars and podcasts.
Research
To support ongoing research programmes with academic institutions and provide small research grants to
support lung cancer nurse specialists taking their first steps in research and those seeking advanced care
practitioner stalus.
LUNG CANCER NURSING UK
IAcharliable incorporot¢d oryanlsètlon ICIO-(tharity Number 11600111
Page 2

TRUSTEES'REPORT
Forthesearended aijanuary 2025
2024 Impact report
The continued pressure of work experienced by lung cancer nurse specialists has not abated during this
period. Significant challenges remain due to high caseloads, staffing shortage5 and increasingly complex
patient cases Wlth multiple morbidity and complex treatment regimens. National guidelines recommend
Caseload of no more than 80 new patients per year but many nurses are exceeding this limit carrying from
between 100 and 200 patients and, as treatments improve and patients live longer there are increasing
ongoing needs of lung cancer survivors that also have to be met.
The struggling workforce impacts on what LCNUK, as a professional organisation, can do to support the
workforce. Increasingly, we have had to resort to the development of short fomi digital media to support
educatlon and professional development as fewer nurses are able to tske time away from the coal face for
meetings and courses.
Efforts have been put in place to support the workforce through the appointment of Navigator5/Cancer Care
Coordinators LCNUK has recognised the growing importance of the role of the Navigator and has opened
up associate members for navigators working in lung cancer with projects ongoing to share best prattice and
optimise the relationship between lung cancer nurse specialist and navigator.
During 2024 membership of all types of members increased slightly to 293.
'Any mernber who paid for a membership in 2020, h35 had their membership end date extended to 2022
Professional
Influencin8 and contribution to natir)nal polky
LCNUK works alongside many organisations across the UK to inforn) lung cancer policy, promote best
practice and act as the patients advocate for people with lung cancer.
In 2024, we contributed to collaborate with national bodies including NICE, BTOG. UKLCC. Roy Castle Lung
Can￿r Foundation and other lung cancer related organisations to support the development of national
policy and guidelines.
The organisation has continued to support Lung Cancer Europe Activities which have had number of
initiatives taking place.
In 2024 we implemented an ambitious programme of work to explore how to assess patient complexity and
its impact on the staffing requirements for lung cancer nurse specialists. A questionnaire was developed and
piloted wlth members of the committee before being taken out to the membership through our annual
project workshop. The outputs of the work will be shared with LCNUK members in June 2025 and through
abstracts submitted to BTOG and the World Conference on Lung Cancer in 2025.
Navigator/supFK)rter roles as described in the N*ional Optimal Lung Cancer Pathway silPPOrt healthcare protessianals by taknng on
administrative and cwrdin3tor rolesto 5UPPOrt Lun8 Can￿r Nurse Specialists and deliver a more patient friendly and patient
centred experience
LUNGCANCER NURSING UK
IAthafftable IncowpoTrted or8anlsatlon ICIO-Charfty Number11600111
Page 3

TRUSTEES, REPORT
Fortheye4rended31Jintsary 2025
Representation
British Thoracic Oncology Group
Clinical Expert Group ILung Cancer)
Global Lung Cancer Coalition
International Thoracic Oncology Nurses Forum
Lung Cancer Europe
Mesothelioma UK
National Lung Cancer Audit
National Institute for Health and Care Excellence
Roy Castle Lung Cancer Coalition
Scottish Medicines Con50rtium
Scottish Lung Cancer Nurses Forum
UK Lung Cancer Coalition
Welsh Lun8 Cancer Nurses Forum
The group has also collaborated and supported gene specific patient groups and Ruth Strau55
Foundation
Developmental
Communlcating with our members
LCNUK has continued to deliver short fomi Succinct Communications with members providin8 bite-size news
and informatlon that can be absorbed in the short window of tirne available to our members. To facilitate
this, we continue to use social media to push out key mes53ges, re8ularly update the content on our website
with direct links from the home page to key important lung cancer 3nd nursing news. We also prepare and
deliver a monthly members newsletter featuring bite-size news and signpostlng members to educational and
professlonal development information as well as updates on key lung cancer news and links to other charity
and not-for-profit news.
Professional
In 2024, LCNUK launched a new £20,000 fund initiative to support leadership training, Member5 fulfilling
specific criteria have the opportunity to apply for grant funding to support NHS approved leadership courses.
Two applications have been received and approved for funding. Those awarded the grant are required to
support LCNUK activities upon completion to share their learning and agree to help mentor future
applicants.
LUNG CANCER NURSING UK
IA¢haritable Inc¢rporated or8ani5aliDD ICIO-Charlty Number 116LMIIII
Page 4

TRUThES' REPORT
Forthowr•nd￿ 31JanuBry2025
Education and clinical
In 2024 we hosted our annual conference at The Hilton Hotel Glasgow. The conference attracted 305
attendees of which 149 were members of LCNUK. 97% ofthosewho completed the evaluation reported
that the Conferen￿ was relevant to their educational needs with similar numbers reporting that the
information was well presented by knowledgeable and appropriate speakers. This was the first time the
conference exceeded delegates since COVID-19 and shows promise for the future role of our annual
conference. In taking the learning from the conference it was agreed that future conferences may offer 3
trial of multi-stream educational content to allow those attending to personalise their conference
experience based on their own learning needs.
The organisation hosted five webinars in 2024 which members could attend live or watch on-demand at
their leisure. These included..
Lung cancer in the LGBTQIA community
May 2024 Peter Barton
Management of Mesothelioma
June 2024 Leah Taylor
Understandlng and managing frailty in lung
cancer
July 2024 Fabio Gomes
Common mental health presentations in lung
cancer
September Asanga Fernando & Jo
2024 Ashcroft
Smoking cessation- how you can support
your patients to qult
Nov 2024 Professor Sanjay Agrawal
In 2024 we also introduced 3 new learning medium by offering members exclusive access to a new podcast
platform. Two podcasts were launched wtth more planned in 2025.
In 2024 we also. in collaboration with Mesothelioma UK, updated existing and produced new resources on
the diagnosis and management of mesothelioma. A dedicated learning module was developed that users
could undertake after studying the resources to test knowledge and receive a certificate of completion for
professional portfolios and CPD.
Research
LCNUK has a small workgroup of active members interested in research {known as RIG- Research Interest
Group) led by Suriya Kirkpatrick.
The group contribute to ongoing lung cancer research projects and promote access to clinical trials.
Regretfully, there were no suitable applications for small grants in 2024. LCNUK recognise this is a symptom
of the pressure on the lung cancer workforce with little to no time available for research work.
29 abstracts were submitted to the LCNUK annual conference {v5 21 in 20231.
Three applications were received for our annual award programme.
LUNG CANCER NURSING UK
IA charltable IncoTporatsd orDni5alipn ICIO-Charlty ￿mber 11600111
Page5

TRUSTFES. REPORT
Forthayearended 31Jènuary2025
Another sub-group of members, the thoracic surgical group. continued working on 3 project, 'Is surglcal
follow-up equiknbleforollpat1ent￿. The results of work will be submitted as an abstract for presentation
at a national conference.
Plans For Future Periods
In 2025, LCNUK will be finalising its plans and implementing a programme of work to develop a patient
complexity tool.
We will be seeking ta influence the national agenda to ensure that patients have timely and appropriate
access to lung cancer nurse specialists to advocate for patients in the lung cancer journey. We will continue
to act as patient representatives and advocates at a national policy level.
We will continue to collaborate with partner organisations to support seNice delivery, timely diagnosis and
appropriate management for people with lung cancer.
We will be collaborating with lung cancer groups in Australia to promote the value of the lung cancer nurse
specialist role.
We will promote best pr2Ctice through the sharing of clinical knowledge and ski115 at our 3nnual flagship
two-day conference in June 2025. Alongside our conference we will continue to deliver digital learning
programmes including webinars. podcasts and online learning modules to support professional
development.
We will work to develop a framework for best practice for navigators/cancer care coordinators and highlight
the benefits of the role in supporting lung cancer nurse specialists to deliver effective and timely care for
people with lung cancer.
We will continue to promote member communications. the sharing and di55emination of relevant lun8
cancer news and information.
In June 2025 we will undertake a strategy revlewto explore howwe can best support LCNUK members and
influence best practice in lun8 cancer care and support in the short medium and longer term.
Structure, Governance & Management
Constitution
The charity is a registered charitable incorporated organisation, charity number 1160011. Formal
membership is open to any lung cancer nurse specialist who spends More than 50Yo of their working week or
clinical activities in caring for patlents with lung cancer or mesothelioma in the UK NHS. In addition.
associate membership is open to healthcare professionals, navigator51cancer care coordinators in a lung
cancer/mesothelioma academic or lung cancerlmesothelioma research role. Such membership is subject to
approval by the LCNUK Committee.
Method of appointment and election of trustees
The management of the charity is the responsibility of the trustees who are elected and co-opted under the
terms of the constitution. During this period the LCNUK was managed by ten trustees, led by Diana
Borthwick who took up the role as chair from 5 January 2024. The trustees, orany member of LCNUK can
LUNG CANCER NURSING UK
IA charitsble I￿OrPOrated organlsatlon ICIO-Charrty Numb*r116r*xii
Page 6

TrUSTEES' REPORT
ForthewJrended 31January2025
recommend a trustee for appointment. One third of the trustees retire each year and may be re-appointed.
Applicants are asked to provide a CV and covering statement. A shortlist is drawn up and interviewed by a
panel appointed by the Board of Trustees. Three co-opted trustees were formally appointed at the AGM in
June 2024 Nicola Handley, Dominic Smith and Catherine Haywood. Lorraine Creech. Isobel Lovett and John
White were reelerted in June 2024, though Isobel Lovett later resigned on 3 July 2024. Despite extensive
efforts the trustees were unable to get hold of Rory Undenmood. A final letter was sent and he was removed
from the board in February 2024. Alison Leary resigned in November 2024.
Policies adopted for the induction and training of trustees
A trustee recruitment and induction pack is available to support new trustees in learning about the
organisation. its role, governance and responsibilities of trustees. The trustee terms of reference and
trustee manual was reviewed and updated in 2024. A trustee skills audit was undertaken in 2024. LCNUK is
also a member of the National Council for Voluntary Organisations to take advantsge of governance training
opportunities.
Organisation structure and decision making
The Trustees are assisted by the LCNUK Committee. The chair of the LCNUK committee attends trustee
meetin8S to ensure continuity and good communications. During 2024 the committee was comprised of 12
elected members of LCNUK and three co-opted members, Suriya Kirkpatrick. Ali50n Edwards and Matthew
Kelly. The LCNUK committee formulates recommendations on the aims, strategies and activities of the
charity for approval by the trustees.
An agency. Red Hot Irons Limited IRHII. is contracted to run the day-to-day business administration and
operations of the organisation.
Pay Policy for key management
There are no paid staff. all work undertaken bythe committee and trustees is done so voluntarily. The
support agency is contracted to run the operational day-to-day activities and business administration.
Application and adherence to the Charity Governance Code
LCNUK recognise good governance is essential to our effectiveness, reputation 3nd credibility. The Board of
Trustees regularly review activities. policies and pro￿55eS to ensure the charity is delivering against its
mission and charitable objectives. We have robust measures in place to ensure effective and clear ovÈNiew
of financial controls. The board undertakes a regular review (every two years) of its effectiveness. assessing
competencies, skills gaps and training needs through a process of external audit and facilitated discussion.
In 2024, LCNUK adopted a new policy on disciplinary procedures and updated its policies on Membership.
Privacy, Safeguarding and Well-bein& Antiharassment and bullying. The investment, reserves and risk
management policies were also reviewed as part of the routine governance of the organisation.
We operate a robust conflicts of interest policy. and all Trustees and Committee members complete
declarations of interest each year. Conflict of interests form a standing item on all committee/board
agend3s. The Board aims to continuously improve its governance processe5 and is currently working through
the new Charit Gove.rn3nce Code to ensure its governance structures adhere to the principles of the code
and recommended prartice.
Risk management
The Trustees analyse and undertake a review of the risks the Charity is exposed to as part of an annual
business planning process and in accordance with Charity Commission guidance (CC26), scoring the risks
LUNG CANCER NiIRSING UK
IAch7ritsble incorporated organlsatlon IC10-C￿rlty Number 11600111
Page 7

TRUSTEES. REPORT
Forthe year￿ded 31Januiry2025
accordin8 to likelihood and impact. The systems and actions established to mitigate those risks are also
reviewed by Trustees at each Board meeting and updated and adjusted accordingly. with the net risk in each
area agreed. High risks closely monitored by the Trustees are:
High level of dependency on too few income streams puts LCNUK at risk of sudden and/or long-term
loss of funding- efforts continue to diversify income streams to include more Trusts and Foundation
as well as funding from non-pharmaceutical companies.
Potential for a sudden drop in income and the need to dip into accumulated reseNes
The risk that LCNUK could be perceived as being unduly influenced by sponsors/pharmaceutical
industry. LCNUK has adopted a strinEent endorsement policy and ensures where possible that there
is a balance of sponsors from across the industry spectrum with no one sponsor having significant
influence or control. Sponsors are not permitted to have any form of editorial control or influence
overthe contentand developmentof new LCNUK branded materials
In 2024, LCNUK opened two new bank accounts to mitigate financial risk and maximise Financial SeNice5
Compensation if required. Further work in this area 15 planned to ensure the safety of funds and maximise
safe return5.
Volunteers
The Society is heavily reli3nt on the time, expertise and energy of rts committee and other members. Much
of the work of the charity is conducted virtually via email and teleconference and is undertaken on a
voluntary basis.
LUNG CANCER NURSING UK
IA ¢h8rltable In¢oryttsrated or8anlsatksn ICIO-Charity Number 11600111
Page 8

TrU5TEts'AEPORT
r thewarended 31J4nu4ry2025
Trustees, executive committee & senior management
Trustees
Accountants
David Baldwin
George Bate Ir&elected 21 June 20241
Diana Borthwick IChair- appointed January 5 20241
Lorraine Creech IT￿elected 21 June 20241
Nicola Handley lelected 21 June 20241
Catherine Haywood (elected 21 June 20241
Allson Leary Iresigned l November 20241
Isobel Lovett (resigned 3 July 20241
Dominit Smith lelected 21 June 20241
Rory Underwood (removed 29 February 20241
John White (re-elected 21 June 20241
Dodd & Co Chartered Accountants
FIFTEEN Rosehill
Montgomery Way
Rosehill Estate
Carlisle
CAI 2RW
Bankers
Unlty Trust bank plc
Nine Brindley place
Bimiingham
812HB
LCNUK Committee
Vlctorta Anderson (resigned Nov 20241
Peter Barton
Karen Clayton ICHAIRI
Pamela Dalrymple
Marie Eaton Isabbatical from June 20241
Annabel Grinberg5 lelerted Nov 20241
Emma Halkyard Ico-optedl
Sarah Ivey (resigned Nov 20241
Lavinia Magee Iresigned Nov 20241
Julia McAdam
Karen Mccrae lelerted Nov 20241
Jennrfer Ross Ire-elected Nov 20241
Paula Shepherd
Charlotte Smith
Bing Smith
Jane Weir (elected Nov 20241
Nationwide Building Society
Nationwide House
Pipers Wav
Swndon
SN38 INW
The Charity Bank Limited,
Fosse House.
182 High Street.
Tonbridge. TN9 IBE
Teachers Building Society..
Allenview House,
Hanham Road,
Wimborne, Dorset,
BH21 IAG
Co-opted LCNUK Committee members
Suriya Kirkpatrick (Research Interest Group Lead)
Matthew Kelly INI representative)
Allson Edwards (Welsh representativel resigned Jan 2025
Registered office
clo Dodd & Co
FIFTEEN Rosehill
Molltgornery Wav
Rosehill Estate
CARLISLE
CAI 2RW
Charity Registeted Number
116(K>ll
WNG fANCER NURSING UK
IAcharitsble in¢orporatsd or£an15atlon ICIO-Charhy Number 11600111
Page 9

TREISTEES. REPORr
Forthéye4rended31J•nuary 2025
Financial Review
Principal Funding
The principal funding sources for the Charity in 2024 as in previous years were:
Voluntary income from the pharmaceutical industry (fees from the LCNUK Corporate Sponsorship)
Income from sponsorship of charitsble activities by pharmaceutical companies andlor solicitors
Membership fees
The total funding secured in 2024. £232.804 an increase of £68,582, this was largely due to the charity
attracting corporate sponsorship from two sponsors. We were also able to attract a grant of £5,000 to
5UPPOrt our leadership programme. We were also able to secure additional investment interest through
spreading income across different bank accounts with increased interest rates which allowed us to attract
£6,808 vs £1,086 in the prior year.
Membership fees were similar to 2024 but we attracted additional paying delegates to the conference
resulting in a conference registration income of £30,793 vs £22,356 in the prior year.
Principal Expenditure
Total expenditure in 2024 was £157,611. This represents an increase in expenditure of £1,672, an increase
of less than 2% on the prioryear. We feel confidentthat we have managed to contain expenditure in spite
of external influences and rising interest rates.
The largest item in support costs was secretsriat, membership and administration costs, which includes fees
paid to Red Hot Irons. Red Hot Irons is contracted to run the day-to-day operations of the charity, including
book-keeping, governance support, maintenance and upkeep of ourwebsite, membership management and
communications. committee management, events, IT, webinars. analytics and database.
Reserves Policv
LCNUK has no regularguaranteed sources of income and the long-term funding of the charity is uncertain.
The charity however does have fixed operating costs in terms of the activities required to maintain its
presence and further its charitable objectives. The charivs work is planned one year in advance with
financial commitments made up to two years in advance on some programmes such as the annual
conference.
The Trustees have therefore decided that to see programmes through to completion in the event of
serious reduction in fundin& an optimal reserve equivalent to twelve months fixed operating costs plus the
annual cost of the conference should be held. This level of reserve also supports the charity in working to a
long-term strategy without the need to make short term adjustments forced on it by temporary deficits in
funding. Moreover. it allows the charity to take advantage of opportunities that may present and require a
relatively small or moderate investment upfront. Minimum and maximum levels of reserves have been
agreed a5 6 months costs and 18 months costs respectively. TheTrustees will be guided only to tske drastic
action if they see the charity falling below its minimum level of reserves and to only make slgnlficant long-
term investments from reserves if the Charity is above its ideal level of reserves.
The optimum level of reserve based on the 2025 budget amounts to £266k with a minimum of £133k. The
level of free unrestricted reserves held by the Society at the end of the accounting period {Jan 20251 was
£403.768, which meets the optimum level of maximum reserves.
LUNG CANCER NURSING UK
(Acharhable inorpDrated or£an157tlan ICIO-Ch8rity ￿mber 11600111
Page 10

TAUSTEES'REPORT
For the￿￿re￿￿￿ 31J4nvJry2a25
The Board undertakes an annual review of the reserves policy to ensure it reflects current activities of the
charity and amounts held in reseNe are sufficient meet the financial and charitable obli8ations should
funding significantly diminish for any reason.
Going concern
After making appropriate enquiries. the Trustees have a reasonable expectation that the charity ha5
adequate resources to continue in operational existence for the foreseeable future. For this reason, they
contlnue to adopt the going concern basis in preparing the financial statements. Further details regardin8
the adoption of the going concern basis can be found in the accounting policies.
Financial Review Conclusion
The Society ended the year with an operating surplus of £75,193 for the accounting period. The charity
continues to hold healthy reserves. However, sponsorship and funding remain a significant thallenge and
operating costs continue to rise particularly around venue hire charges and insurance costs. The Trustees
recognise that the funding situation remains challenging and will continue to be innovative in our approach
to fundraisin& cost savings and ensuring value for money. We will also look to achieve additional funding
from grant making bodies.
Statement of Trustees, responsibilities
The Trustees are responsible for preparing the Trustees, report and the financial Statements in accordance
with applicable law and United Kingdom Accounting Standards Iunited Kingdom Generally Accepted
Accountin8 Practice).
Charity law requires the Trustees to prepare financial statements for each financial year. Under charity law
the Trustees must not approve the financial statements unless they are satisfied that they give a true and
fair view of the state of affairs of the Charity and of its incoming resources and application of resources,
including its income and expenditure, for that period. In preparing these financial statements, the Trustee5
are required to-
select suitable accounting policies and then apply them consistently.
observe the method5 and principles of the Charities SORP (FRS 102};
make judgments and accounting estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards IFRS 1021 have been followed, subject to any
material departures disclosed and explained in the financial statements:
prepare the financial statements on the going concern basis unless it is inappropriate to presume
that the charity will continue in business.
The Trustees are responsible for keeping adequate accounting records that are sufficient to show and
explain the charity's transactions and disclose with reasonable accuracy at any time the financial position of
the charity and enable them to ensure that the financial statements comply with the Charities Act 2011.
They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for
the prevention and detection of fraud and other irregularities.
LUNG CANCER NURSING UK
(A charltable incorporatsd OT8anlsatlan ICIO-Chorfrty Number 11600111
Page 11

TRUSTE￿. REPOHT
FortheyeèrEnd￿ 31Jihutry2025
Disclosure of information to independent examiner
Each of the person5 who are Trustees at the time when this Trustees, report is approved has confirmed that:
so far as that Trustee is aware. there is no relevant information of which the charity's accountant
and independent examinerare unaware, and
that Trustee has taken all the steps that ought to have been taken as a Trustee in order to be aware
of any relevant informatlon and to establish that the charity's accountants are aware of that
information.
Approved by order of the members ofthe board of Trustees and signed on their behalf by:
Diana Borthwick
Chair of the Board of Trustees
Date:
a￿)061￿C)2
LUNG C4NCER NURSING UK
IA¢harftablÈ IrKorpor3ted or8anivtiw ICIO-Charhy Nurnber 11600111
Page 12

Ind6pendent Examinerfs Report to the Trustaos of
Lung Cancer Nursing UK
I report on the accounts of the ¢harily for the year ended 31 January 2025, which are Set out on pages 14 to 22.
Your attention is to drawn to the fact that the Charity has prepared the financial statements in accordance with
Accounting and Reporting by Charities Preparing their accounts in accordance with the Financial Reporting
Standard applicable in the UK and Republic of Ireland IFRS 1021 in preference to the Accounting and Reporting
by Chartties.. Statement of RecornTnended Practice issued on 1 April 2005 which is referred to in the extant
regulations bul has since been withdrawn.
We understand that this has been done in order for the accnunts to provide 8 true and fair view in accordance
with the Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January
2019.
Respective responsibilities of trustees and examiner
The Charity's trustees are responsible for the preparation of the accounts. The trustees consider that an audit is
not required for this year under section 144{2) of the Chartties Acl 201 I as amended by the Charities Act 2022
{the Act) and that an independent examination is needed.
It is my rasponsibility to..
examine the accounts under section 145 of the Act.,
follow the Pro￿dureS laid down in the General Directions given by the Charity Commission under section
14515) Ibl Of the Act., and
stste whether particular matters have come to my attenlion.
Ba818 of independent axaminerfs report
My examinab'on was carried out in accordan￿ thi the General D1￿CtionS given by the Charity Commission. An
examination includes a review of the accounting records kept by the charity and a comparison of the accounts
presented wth those records. It also inciudes ¢onsideration of any unusual items or disdtssures in the accounts.
and seeking explanations from you as trusteès conceming any such matters, The procedures undertaken do not
provide all the evidence that would be required in an audit and consequently no opinion is given as to whether
the accounts present a 'lrue and fair view, and the report is limited to those matteTS set out in the statement
below.
Independent examinevs statement
In connection with my examinalian, no matter has come to my attention-
{11 which gives me reasonable cause to believe that in any material respect the requirements=
to keep accounting records in accordan￿ with section 130 of the Charities Act 2011 as
amended by the Charities Act 2022., and
to prepare accounts which accord with the accounting records, comply with the accounting
requirements of the Act
have not been met.. or
12) to which, in my opinion, attention should be drawn in order to enable a proper understanding of the
accounts to be reached.
FIFTEEN Rosehill
Montgomery Way
Rosehill Estate
CARLISLE
CA1 2RW
nne Thom
Inson FCA
d & Co Limited
Chartered Accountants
12 May 2025
Page 13

Lung Cancer Nursing UK
known as
LCNUK
ststement of Financial Activities for the Year Ended 31 January 2025
Unrestricted Total Funds Totsl Funds
Fund$
2025
2024
Income and endowments from:
Donations and legacies
Inveslment income
Charitable activities
Total income
162,845
6,808
63,151
232,804
162,845
6,808
63,151
232,804
123.100
1,086
40,036
164,222
Expendlture on:
Charitable activities
Total expenditure
157,611
157,611
157,611
157,611
155,939
155,939
Netmovements in funds
75,193
75,193
8.283
Reconciliation of funds
Total funds brought forward
Totsl fvnds carried forward
328,575
403,768
328,575
403,768
320.292
328,575
The notes on pages 16 to 22 foTm an integral part ofthese financial ststements.
Page 14

Lung Cancer Nursing UK
trading as
LCNUK
Balance Sheet as at 31 January 2025
2025
2024
Note
Cuffent assets
Debtors
Cash al bank and in hand
10
58,401
375.181
48,232
338.078
433,582
386,310
Creditors: Amounts falling due within
one ￿ar
11
129,8141
157,735)
Net current assets
403,768
328,575
Net assets
403,768
328,575
The funds of the charity:
Unrestricted fvnds
Unrestricted income funds
403,788
328.575
Total charity funds
The finanaal statements have been prepared in accordance with the Finanaal Reporting Standard applicable in
Ihe UK and Republic of Ireland IFRS 1021.
403,768
328,575
Approved by the Board on 12 May 2025 and signed on its behalf by..
D Borthwick
Trustee
The notes on pages 16 to 22 fomi an integral part ofthese financial statements.
Page 15

Lung Cancer Nur8lng UK
known as
LCNUK
Notes to tha Flnancial Statam8nts for the Year Ended 31 January 2025
Accounting pollcles
Statement of complTance
The accounts (financial ststements) have been prepared under the historical cost convention wth items
recognised at cost or transaction value unless otherwise stated in the relevant note{sl to these accounts.
The financial statements have been prepared in accordan￿ with the second edrtion of the Charitses
Statement of Recommend￿1 Practice issued in October 2019. the Finan￿al Reportrng Standard applicable
in the United lQngdom and Republic of Ireland IFRS 102) and the Charities Act 2011 as amended bv the
Charibes Act 2022.
The accounts Ifinanual statements) have been prepared to give 8 'true and fairf view and have departed
from the Chatitses (Accounts and Reports) Regulations 2008 only to the extent required to provide a 'true
and fair view. This departure has involved following Accounting and Repo￿ng by Charities preparing their
accounts in accordance with the Financial Reporting Stsndard applicable in the UK and Republic of Ireland
(FRS 1021 rather than the Accounting and Reporting by Charities'.Statement of Recommended Practi
effective from 1 April 2005 which has since been withdrawn.
Basis of prgparation
The charity meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially
recognised at historical cosl or transaction value unless otheNise stated in the relevant accounting policy
notes.
Going concom
These financial ststements have been prepared on a going concern basis.The trustees assess whether the
use of going conc&m is appropriate i.e. whether there are any material uncertainties related to events or
conditions that may cast significant doubt on the ability of the Charity to continue as a going concem. The
trustees make this assessment in r•spect of a period of one year from the date of approval of the financial
sL8tements.
Fund accounting policy
Unrestrictod Income funds are general funds that are available for use at the trustees, discretion in
furtherance ofthe objeclives of the charity.
Further details of each fund are disdosed in note 13.
Income and endowments
Donations and legacies induding gifts are recognised where there is entitlement, probability of receipt and
the amount L3n be measured suffiaent reliability.
Income from Govemment and other grants. whether'capital. grants or'revenue, grants, is recognised when
the charity has entitlement to the funds, any performance condiknons attached to the grants have been met,
it is probable that the income will be received and the amount can be measured reliably and is not deferred.
Investrnent income is recognised on a re￿1vable basis.
In¢ome from charitsble actiwtl8s include5 income recognised as eamed {as the related goods or services
are provided) under contract.
Membership income is re￿gnised on receipt
Page 16

Lung Cancer Nurslng UK
known as
LCNUK
Notes to the Financial Statements for the Year Ended 31 January 2025
conlinu8d
Expendlture
Liabilities are recognised as soon as there is a legal or constrL¢ciive obligation committing the ¢harity to the
expenditure. All expenditure is accounted for on an accruals basis and has teen dossified under headings
that aggregate all costs related to the category.
Expenditure on raising funds are the costs of trading for fundraising pu￿oses.
Charitable expenditura compris6s those costs incurred by the charity in the delivery of tts aC￿￿tieS and
services for its beneficiaries. It includes both costs that can be allocated directly to such actiwiies and ihose
costs of an indirect nature necessary to support them.
Grants payable are payments made to third parties in the furtheran￿ of the oharitable objectives. Where
the charity gives a grant with conditions for its payment being a specific level of service tsr output to be
provided, such grants are only recognised in the SOFA On￿ the recipient of the grant has provided the
specifiG servtce or output.
Grants payable without performance conditions are only recognised in the accounts when a commitment
has been made and there are no conditions lo be met relating to the grant which remain in the control of the
charity.
Provision8 for grants are made when the inlention to make a grant has been communicated to the recipient
but there is uncertainty 8bout either the timing of the grant or the amount of gr8nt payable.
Support costs
Support costs include central functions and have been allocated to activity cost categories on a basis
consistent with the use of resources. for example, allo¢ating propety costs by floor areas, or per capita,
stsff costs by the time spent and other costs by their usage.
Irrocoverable VAT
Irrecoverable VAT is charged against the category of resour￿8 expended for which it was incurred.
Cash and Cash Equivalènts
Cash and cash equivalents comprise cash on hand and call deposits, and other short-temi highly liquid
investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of
change in value.
Donations and1ogaci8s
Unrastrlcted Total Funds Totsl Funds
Funds
2025
2024
Donatlons and legacies
Conference sponsorship
Corporate sponsorship
140,845
22,000
162,845
140,845
22,000
162,845
123,100
123,100
Of the donations and legaaes income in 2024 £123.100 related to unrestricted funds.
Page 17

Lung Cancer Nurslng UK
known as
LCNUK
Notes to the Financial Statements forth8 Yaar Ended 31 January 2025
. continued
Investrnant income
Unrostri¢tsd Total Funds Total Fund8
Funds
2025
2024
Interest on cash deposits
6,808
6.808
1,086
Of the investment income in 2024 £1,086 related to unrestricled funds.
Charitsble activities
Unrestrlcted Total Funds Total Funds
Funds
2025
2024
Membership and re$ear¢h
Representation income
Membership subscriptions
1,017
7,920
8,937
7,740
7.740
7,740
7,740
Annual conference
Conference exhibition only
Delegate registration
19,618
30.793
50,411
19,618
30,793
50.411
8,743
22,356
31,099
Online Education
Leadership programme income
5,000
5,000
63.151
63,151
40,036
OF the income from charitable activtties in 2024 £40,036 related to unrestricted funds.
Page 18

Lung Cancer Nury3ing UK
known as
LCNUK
Notes to the FinanGial Statements for the Year Ended 31 January 2025
. continu8d
Expenditure
Membership
and
rèsèarch
Annual
conference
Online
Education
Totsl
2025
Totsl
2024
Dire¢t Costs
Grants payable - individuals
Webinar costs
Leadership programme
expenditure
Membership administration costs
TSG committee costs
Website costs
Navigator group expenditure
Dependency lotsl
RIG ¢osts
Annual workshop
Online learning
Venue costs
Speaker costs and tokens
Management fees
conferen￿ costs - materials
Conference costs - other
Irrecoverable VAT
1984)
1984}
5,846
4,455
12,533
1,061
4,328
570
10,113
4,000
5,846
4,455
12,533
1,061
4,328
570
11,699
1,148
4.545
225
110
1,171
6,789
110
54,804
2,025
11,500
16,709
14.806
{4771
139,277
1,936
8,333
2,708
1,936
8,333
2.708
43,664
3,444
11,500
20,088
19,437
43,664
11,500
20.068
19,437
31.469
97,129
10,301
138,899
Supportcosts
Insuran
off1￿management
Committee costs
Representation ¢osts
Accountancy and bookkaeping
fees
Independent examinarts lee
Bank charges
276
2,531
1.019
108
276
2,530
1,018
108
276
2,530
1,018
108
828
7,591
3,055
324
740
5.743
1,801
1.391
1,611
216
477
6,238
1.612
1,612
4.835
650
1,429
18,712
5.090
217
476
6,237
217
476
6,237
650
1,247
16,662
37,707
103,366
16,538
157,611
155,939
Of the total expenditure in 2024 £155,939 related to unrestricted funds.
Page 19

Lung Cancer Nursing UK
known as
LCNUK
Notss to the Financial Statements for the Year Ended 31 January 2025
. conlinued
Grantmaklng
Grants to
individuals
Annual conference
1984)
Governance costs
2025
2024
Trustee meeting costs
Accountsncy fees
Bookeeping fees
Independent examiners fee
677
1,685
3,150
650
6,162
410
1,905
3,150
650
6,115
Tru$ts•s' r•mun•ration and expenses
Committee meeting and travel expenses totalling £387 (2024.. £3321 were paid to 4 {2024.- 11 of the
trustees during the year.
Page 20

Lung Cancer Nursing UK
known as
LCNUK
Notes to the Financlal Statements forthe Year Endad 31 January 2025
. ￿ntInued
Taxation
The registered charity is exempt from taxation on income and gains.
10 Debtors
2025
2024
Trade debtors
Other deblors
Prepayments and accTued income
47,858
7,453
50,948
58,401
374
48,232
11 Creditors: Amounts falling due within one wr
2025
2024
Trade creditorE
Taxation and so¢ial security
Other creditors
Accruals and deferr6d income
1,787
116
6,919
340
27.687
29,814
50,700
57,735
Page21

Lung Cancer Nursing UK
known as
LCNUK
Notes to the Financial Statements for the Year Endad 31 January 2025
. conlinued
12 Related parties
Controlling entity
The Charity is wntrolled by the trustees.
13 AnatyBis of fvnds
At1
Fèbruary
2024
In¢oming
resources
Rosource8
At31
axpendod January 2025
General Funds
Unrestricled income fvnd
Prior ￿ar
328,575
232,804
{157,611)
403,768
Atl
February
2023
Incoming
resources
Resources
At31
expendgd January 2024
General Funds
UnrestriGed income fund
320,292
164.222
{155,939)
328,575
14 Nat agsets by fund
Unrestricted
Funds
Total Funds
2025
Totsl Funds
2024
Current assets
Creditors.. Amounts falling due within one year
Net assets
433,582
129,8141
403,768
433,582
129,8141
403,768
386,310
{57,735)
328,575
Prior year
Unrestrictgd
funds
Total fund8
2024
Total fundg
2023
Culrent assels
Creditors.. Amounts falling due within one year
Net asset5
386.310
157,7351
328,575
386,310
157.735)
328,575
332,710
{12,4181
320,292
Page 22